IVERIC bio, Inc. Restructuring and Related Cost, Expected Cost
IVERIC bio, Inc. had Restructuring and Related Cost, Expected Cost of $13.30 million as of 2017-09-30, per its 10-Q filed 2017-11-08.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringAndRelatedCostExpectedCost1 · last filed 2018-03-05
- 2017-09-30: Restructuring and Related Cost, Expected Cost $13.30M.
- 2017-01-31: Restructuring and Related Cost, Expected Cost $13.10M.
| Period end | Restructuring and Related Cost, Expected Cost |
|---|---|
| 2017-09-30 | $13.30M 10-Q · filed 2017-11-08 |
| 2017-01-31 | $13.10M 10-K · filed 2018-03-05 |